Combination Therapy Current Events | Combination Therapy News | 8
|
| Page
8 of
50 |
998 Results |
|
|
|
Sort By:
Page Views | Date |
Time to reassess the value of HRT
It may be time to reassess the value of hormone replacement therapy, following evidence that it reduces the effectiveness of breast screening and causes breast cancer in women over the age of 50, says a leading breast surgeon in this week's BMJ. Increasing numbers of women in their 50s and 60s are using hormone replacement therapy to alleviate... view more... (2001-12-12)
Combining PET and CT scans makes cancer treatment more accurate
Doctors have discovered that combining images derived from positron emission tomography and computed tomography in the planning and delivery of radiation treatment for patients with head and neck cancer leads to more accurate delivery of the radiation dose and an increased chance for survival. view more (2006-05-02)
Study finds major interruptions in antiretroviral therapy after release from prison
The vast majority of HIV-infected Texas prison inmates who receive antiretroviral therapy while incarcerated experience significant interruptions in HIV treatment after their release into the community. view more (2009-02-25)
New protocol streamlines therapy that makes more kidney transplants possible
A new therapy developed at Cedars-Sinai Medical Center improves transplant rates and outcomes for patients awaiting living- and deceased-donor kidney transplantation, according to a study published in the July 17 issue of the New England Journal of Medicine. view more (2008-07-17)
Tibotec presents interim findings for TMC435, an investigational genotype 1 hepatitis C treatment
New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection. view more (2008-11-04)
Targeted therapy plus chemotherapy may pack 1-2 punch against melanoma
By targeting and disabling a protein frequently found in melanoma tumors, doctors may be able to make the cancer more vulnerable to chemotherapy, according to a new study by researchers in the Duke Comprehensive Cancer Center. view more (2008-05-15)
New combination therapy safe, promising for melanoma patients
The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. view more (2008-06-02)
Mechanical 'artificial hearts' can remove need for heart transplant by returning heart to normal
Mechanical 'artificial hearts' can be used to return severely failing hearts to their normal function, potentially removing the need for heart transplantation, according to new research. view more (2006-11-02)
Polymorphism and antibodies associated with highly increased risk of rheumatoid arthritis
People who have a specific genetic variant of the PTPN22 gene and test positive for antibodies against cyclic citrullinated peptide are much more at risk of developing rheumatoid arthritis than people who only have one of these markers. view more (2005-12-22)
A novel mechanism of action for anti-tumor agent, CA4P
Anti-angiogenic agents have been successful in the clinic for blocking the growth of solid tumors. However, these agents used in combination with chemotherapy have improved the survival of patients with cancers by only several months. view more (2005-10-07)
Keeping cancer at bay: Long-term therapy in the fight against multiple myeloma
There is no known cure for multiple myeloma, so its diagnosis means high-dose chemotherapy followed by repeated treatments with each relapse of the cancer - a watch and wait approach. view more (2006-11-06)
New Treatment for Radiotherapy-Induced Side Effects Developed at Oxford
As seen in recent health news reports, treatments for side effects associated with radiotherapy are in high demand. An Oxford University scientist at the Research Institute of Oxford’s Churchill Hospital has invented a new non-toxic compound therapy that has shown positive results in the treatment of radiotherapy-induced side effects. This... view more... (2002-10-09)
First Parkinson's Gene Therapy Patient Passes One Year
The first ever patient to have undergone gene therapy for Parkinson's appears to have come through phase I without a hitch, suggesting that the therapy is safe and effective, reports Marina Murphy in Chemistry & Industry. view more (2004-09-02)
High-dose radiation reduces risk of prostate cancer recurrence
Men with localized prostate cancer who received high-dose external radiation therapy were less likely to have cancer recurrence than men who received conventional-dose radiation therapy. view more (2005-09-14)
Rat makes a partial recovery following a spinal cord lesion
Scientists at the Netherlands Institute for Brain Research have developed an experimental therapy which enables rats with a spinal cord lesion to partially recover from their paralysis. Up until now not even the slightest degree of recovery was possible. PhD student Bas Blits was part of this team. The method uses a combination of transplantation... view more... (2002-02-19)
Researchers identify the three killer indicators that are even worse than high cholesterol
Researchers at the University of Warwick have identified a particular combination of health problems that can double the risk of heart attack and cause a three-fold increase in the risk of mortality. view more (2009-11-03)
Occupational therapy improves quality of life for dementia patients and their carers
Occupational therapy can help to improve the ability of people with dementia to perform daily activities and can also reduce the pressure on their caregivers. view more (2006-11-17)
First report that apoptotic and anti-angiogenic therapies work better together than alone
American researchers have found that giving a combination of imantanib (Glivec) and a drug that induces cell death (apoptosis) was better at inhibiting the growth of Ewing's sarcoma in mice than either therapy on its own. view more (2006-11-13)
Anti-HIV Therapy Boosts Life Expectancy
The life expectancy for patients with human immunodeficiency virus (HIV) has increased by more than 13 years since the late 1990s thanks to advancements in antiretroviral therapy, according to researchers at the University of Alabama at Birmingham (UAB) and Simon Fraser University in Vancouver, British Columbia. view more (2008-07-28)
Fox Chase finds all-biologic regimen efficacious and well-tolerated in elderly lung cancer patients
Previously untreated non-small cell lung cancer (NSCLC) patients over the age of 70 respond well to a combination of bevacizumab and erlotinib, Fox Chase Cancer Center researchers reported today at the annual meeting of the International Association for the Study of Lung Cancer. view more (2009-08-03)
|
|
| Page
8 of
50 |
998 Results |
|
|
|
Sort By:
Page Views | Date |
|
